vs
六旗（FUN）与VERACYTE, INC.（VCYT）财务数据对比。点击上方公司名可切换其他公司
六旗的季度营收约是VERACYTE, INC.的1.6倍（$225.6M vs $139.1M），VERACYTE, INC.净利率更高（20.6% vs -119.0%，领先139.7%），VERACYTE, INC.同比增速更快（21.5% vs 11.7%）
六旗娱乐是总部位于美国北卡罗来纳州夏洛特的游乐园运营企业，由雪松会与原六旗公司于2024年7月1日对等合并而成，是全球最大的区域性游乐园运营商。旗下共运营42个场地，包含27座游乐园、15座水上乐园，配套9处 onsite 度假物业。
Veracyte是一家领先的分子诊断企业，专注开发专有的基因组检测方案，可实现癌症及其他复杂疾病的早期精准检测，产品服务于医疗机构以优化临床决策，核心市场位于美国，正稳步拓展全球业务布局。
FUN vs VCYT — 直观对比
营收规模更大
FUN
是对方的1.6倍
$139.1M
营收增速更快
VCYT
高出9.8%
11.7%
净利率更高
VCYT
高出139.7%
-119.0%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $225.6M | $139.1M |
| 净利润 | $-268.6M | $28.7M |
| 毛利率 | — | 72.7% |
| 营业利润率 | — | 16.3% |
| 净利率 | -119.0% | 20.6% |
| 营收同比 | 11.7% | 21.5% |
| 净利润同比 | -22.2% | — |
| 每股收益（稀释后） | — | $0.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FUNVCYT
| Q1 26 | $225.6M | $139.1M | ||
| Q4 25 | $650.1M | $140.6M | ||
| Q3 25 | $1.3B | $131.9M | ||
| Q2 25 | $930.4M | $130.2M | ||
| Q1 25 | $202.1M | $114.5M | ||
| Q4 24 | — | $118.6M | ||
| Q3 24 | $1.3B | $115.9M | ||
| Q2 24 | $571.6M | $114.4M |
净利润FUNVCYT
| Q1 26 | $-268.6M | $28.7M | ||
| Q4 25 | $-92.4M | $41.1M | ||
| Q3 25 | $-1.2B | $19.1M | ||
| Q2 25 | $-99.6M | $-980.0K | ||
| Q1 25 | $-219.7M | $7.0M | ||
| Q4 24 | — | $5.1M | ||
| Q3 24 | $111.0M | $15.2M | ||
| Q2 24 | $55.6M | $5.7M |
毛利率FUNVCYT
| Q1 26 | — | 72.7% | ||
| Q4 25 | 91.4% | 72.5% | ||
| Q3 25 | 91.6% | 69.2% | ||
| Q2 25 | 91.3% | 69.0% | ||
| Q1 25 | 89.3% | 69.5% | ||
| Q4 24 | — | 66.4% | ||
| Q3 24 | 91.9% | 68.2% | ||
| Q2 24 | 90.7% | 68.1% |
营业利润率FUNVCYT
| Q1 26 | — | 16.3% | ||
| Q4 25 | -3.8% | 26.4% | ||
| Q3 25 | -83.7% | 17.4% | ||
| Q2 25 | 8.0% | -4.0% | ||
| Q1 25 | -158.9% | 2.5% | ||
| Q4 24 | — | 3.5% | ||
| Q3 24 | 19.5% | 10.4% | ||
| Q2 24 | 21.6% | 4.0% |
净利率FUNVCYT
| Q1 26 | -119.0% | 20.6% | ||
| Q4 25 | -14.2% | 29.3% | ||
| Q3 25 | -90.1% | 14.5% | ||
| Q2 25 | -10.7% | -0.8% | ||
| Q1 25 | -108.7% | 6.2% | ||
| Q4 24 | — | 4.3% | ||
| Q3 24 | 8.2% | 13.1% | ||
| Q2 24 | 9.7% | 5.0% |
每股收益（稀释后）FUNVCYT
| Q1 26 | — | $0.35 | ||
| Q4 25 | $-0.93 | $0.50 | ||
| Q3 25 | $-11.77 | $0.24 | ||
| Q2 25 | $-0.99 | $-0.01 | ||
| Q1 25 | $-2.20 | $0.09 | ||
| Q4 24 | — | $0.07 | ||
| Q3 24 | $1.10 | $0.19 | ||
| Q2 24 | — | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $116.5M | $439.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $279.2M | $1.3B |
| 总资产 | $7.7B | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FUNVCYT
| Q1 26 | $116.5M | $439.1M | ||
| Q4 25 | $91.1M | $362.6M | ||
| Q3 25 | $70.7M | $315.6M | ||
| Q2 25 | $107.4M | $219.5M | ||
| Q1 25 | $61.5M | $186.1M | ||
| Q4 24 | — | $239.1M | ||
| Q3 24 | $89.7M | $274.1M | ||
| Q2 24 | $52.9M | $235.9M |
总债务FUNVCYT
| Q1 26 | — | — | ||
| Q4 25 | $5.2B | — | ||
| Q3 25 | $5.0B | — | ||
| Q2 25 | $5.3B | — | ||
| Q1 25 | $5.0B | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $4.6B | — | ||
| Q2 24 | $2.3B | — |
股东权益FUNVCYT
| Q1 26 | $279.2M | $1.3B | ||
| Q4 25 | $549.8M | $1.3B | ||
| Q3 25 | $614.3M | $1.3B | ||
| Q2 25 | $1.8B | $1.2B | ||
| Q1 25 | $1.8B | $1.2B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | $2.3B | $1.2B | ||
| Q2 24 | — | $1.1B |
总资产FUNVCYT
| Q1 26 | $7.7B | $1.4B | ||
| Q4 25 | $7.8B | $1.4B | ||
| Q3 25 | $7.9B | $1.4B | ||
| Q2 25 | $9.5B | $1.3B | ||
| Q1 25 | $9.2B | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | $9.4B | $1.3B | ||
| Q2 24 | $2.3B | $1.2B |
负债/权益比FUNVCYT
| Q1 26 | — | — | ||
| Q4 25 | 9.40× | — | ||
| Q3 25 | 8.16× | — | ||
| Q2 25 | 2.97× | — | ||
| Q1 25 | 2.75× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.95× | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $35.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 1.23× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FUNVCYT
| Q1 26 | — | $35.2M | ||
| Q4 25 | $-37.7M | $52.6M | ||
| Q3 25 | $356.2M | $44.8M | ||
| Q2 25 | $187.0M | $33.6M | ||
| Q1 25 | $-178.0M | $5.4M | ||
| Q4 24 | — | $24.5M | ||
| Q3 24 | $337.4M | $30.0M | ||
| Q2 24 | — | $29.6M |
自由现金流FUNVCYT
| Q1 26 | — | — | ||
| Q4 25 | $-109.3M | $48.8M | ||
| Q3 25 | $256.2M | $42.0M | ||
| Q2 25 | $18.8M | $32.3M | ||
| Q1 25 | $-318.0M | $3.5M | ||
| Q4 24 | — | $20.4M | ||
| Q3 24 | $227.7M | $27.7M | ||
| Q2 24 | — | $26.8M |
自由现金流率FUNVCYT
| Q1 26 | — | — | ||
| Q4 25 | -16.8% | 34.7% | ||
| Q3 25 | 19.4% | 31.8% | ||
| Q2 25 | 2.0% | 24.8% | ||
| Q1 25 | -157.4% | 3.1% | ||
| Q4 24 | — | 17.2% | ||
| Q3 24 | 16.9% | 23.9% | ||
| Q2 24 | — | 23.4% |
资本支出强度FUNVCYT
| Q1 26 | — | — | ||
| Q4 25 | 11.0% | 2.7% | ||
| Q3 25 | 7.6% | 2.1% | ||
| Q2 25 | 18.1% | 1.0% | ||
| Q1 25 | 69.3% | 1.6% | ||
| Q4 24 | — | 3.5% | ||
| Q3 24 | 8.1% | 1.9% | ||
| Q2 24 | — | 2.4% |
现金转化率FUNVCYT
| Q1 26 | — | 1.23× | ||
| Q4 25 | — | 1.28× | ||
| Q3 25 | — | 2.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.76× | ||
| Q4 24 | — | 4.80× | ||
| Q3 24 | 3.04× | 1.98× | ||
| Q2 24 | — | 5.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FUN
| In-park admissions revenues | $113.4M | 50% |
| In-park product revenues | $89.0M | 39% |
| Out-of-park revenues | $28.8M | 13% |
VCYT
| Testing revenue | $135.1M | 97% |
| Product revenue | $3.7M | 3% |
| Biopharmaceutical and other revenue | $301.0K | 0% |
